Irbesartan suppresses lipopolysaccharide (LPS)-induced blood–brain barrier (BBB) dysfunction by inhibiting the activation of MLCK/MLC
Qixia Yang, Juanjuan Yu, Hao Qin, Long Liu, Chao Di, Qiang Zhuang, Hang Yin
Topics & Concepts
IrbesartanOccludinBlood–brain barrierTight junctionPharmacologyLipopolysaccharideCell biologyMedicineChemistryEndocrinologyBiologyCentral nervous systemBlood pressureBarrier Structure and Function StudiesNeurological Disease Mechanisms and TreatmentsDrug Transport and Resistance Mechanisms